Wondering what is the best GLP 1? Compare semaglutide, tirzepatide, and liraglutide on weight loss results, dosing, side effects, and cost.
There is no single best GLP-1 for everyone. Tirzepatide, sold as Mounjaro and Zepbound, has produced the largest average weight loss in clinical trials, while semaglutide, sold as Ozempic and Wegovy, is the most studied and the most widely covered by US insurance plans. If you are asking what is the best glp 1, the honest answer is that the best one is the medication your clinician recommends for your health profile and that you can tolerate and afford long term.
GLP-1 medications copy a gut hormone your body releases after meals. They slow stomach emptying, increase feelings of fullness, and calm appetite signals in the brain. They are treatments, not cures, and many people regain weight after they stop taking them.
Anyone reading up on gut hormones will eventually encounter the difference between glp-1 and glp-2, since the two receptors sit in different tissues and do not produce the same metabolic effects.
What Best Actually Means for a GLP-1 Medication
Best is rarely a single number. In practice it comes down to four factors:
- Effectiveness: how much weight loss or blood sugar improvement the drug delivers on average.
- Tolerability: whether you can handle nausea, constipation, or reflux without stopping.
- Access: whether your insurance covers it and whether your pharmacy can keep it in stock.
- Convenience: weekly injections, daily injections, or a daily pill.
Two people at the same starting weight can respond very differently to the same drug, so trial averages are a starting point rather than a promise.
How the Leading GLP-1 Medications Compare
| Medication (brand) | Active ingredient | Schedule | Average weight loss in trials | Main FDA-approved use |
|---|---|---|---|---|
| Zepbound / Mounjaro | Tirzepatide (GLP-1 plus GIP) | Once weekly injection | About 21% at 15 mg over 72 weeks | Chronic weight management; type 2 diabetes |
| Wegovy / Ozempic | Semaglutide | Once weekly injection | About 15% at 2.4 mg over 68 weeks | Chronic weight management; type 2 diabetes |
| Saxenda / Victoza | Liraglutide | Once daily injection | About 8% at 3.0 mg over 56 weeks | Chronic weight management; type 2 diabetes |
| Trulicity | Dulaglutide | Once weekly injection | Modest, roughly 3 to 5% | Type 2 diabetes |
| Rybelsus | Oral semaglutide | Once daily by mouth | Modest, roughly 4 to 6% | Type 2 diabetes |
Tirzepatide and semaglutide lead the field on weight loss, and both are FDA-approved for chronic weight management. Liraglutide and dulaglutide are older options that still work well for many people, especially when cost or coverage points in their direction.
Which GLP-1 Is Best for Your Goal?
If weight loss is the main goal
Tirzepatide produced roughly 21% average body weight loss at the 15 mg dose over 72 weeks in the SURMOUNT-1 trial. Semaglutide 2.4 mg produced about 15% over 68 weeks in the STEP 1 trial. Those figures are averages across hundreds of participants, not a prediction for any one person.
If blood sugar control is the main goal
Semaglutide, dulaglutide, liraglutide, and tirzepatide all lower A1C and are approved for type 2 diabetes. Tirzepatide and semaglutide tend to produce the largest A1C reductions in published studies.
If cost is the deciding factor
Generic liraglutide is now available in the United States, and some insurers place it on a lower tier than brand-name options. Manufacturer savings cards, pharmacy discount programs, and insurance appeals can also change your out-of-pocket price dramatically.
Side Effects, Safety, and Who Should Avoid GLP-1s
Nausea, vomiting, diarrhea, constipation, and abdominal pain are the most common side effects, and they usually ease as the dose stabilizes. Serious but rare risks include pancreatitis and gallbladder disease.
GLP-1 medications are not recommended during pregnancy, and they are contraindicated for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome. Rapid weight loss can also cost lean muscle, so protein intake and resistance training matter during treatment.
People with a history of eating disorders, kidney disease, or diabetic retinopathy should discuss their risks with a clinician before starting. GLP-1 drugs are prescription medications, and self-dosing with unapproved products is not safe.
Compounded GLP-1s, Peptides, and What to Watch Out For
Compounded semaglutide and tirzepatide became popular during the 2022-2024 shortages. The FDA now considers those shortages resolved, which sharply limits when a compounding pharmacy may legally prepare a copy of a brand-name GLP-1.
If you are comparing compounded options, it helps to understand what is the difference between semaglutide and tirzepatide compound before you look at prices, because the two drugs use different dosing schedules and are not interchangeable.
Research peptides sold for laboratory use only are a separate category. People searching for what is the best peptide company often assume that a popular vendor equals a safe product, but no rating guarantees a vial is sterile, correctly dosed, or free of contaminants. In lab settings, questions such as what is the best bac water for peptides come up because bacteriostatic water affects how a reconstituted powder is stored, yet none of that makes an unapproved peptide safe to inject.
Newer compounds are also moving through clinical trials. Learning what is the retatrutide peptide can help you follow the headlines, but retatrutide remains investigational and is not FDA-approved for any use.
How to Choose a GLP-1 With Your Doctor
Bring a short list of questions to your appointment:
- Which GLP-1 fits my health history, current medications, and lab results?
- What dose will I start on, and how quickly will it increase?
- Which side effects should make me call you right away?
- Will my insurance cover this, and what happens if it does not?
- What is the plan if I need to stop the medication?
The best GLP-1 is the one that is appropriate for your body, affordable under your plan, and sustainable for the long run. A licensed clinician or pharmacist is the right person to make that decision with you.
Frequently Asked Questions
What is the best GLP-1 for weight loss?
Tirzepatide, sold as Zepbound, has produced the largest average weight loss in clinical trials, about 21% of body weight at the highest dose, followed by semaglutide, sold as Wegovy, at roughly 15%. Individual results vary widely, and a prescriber may recommend a different option based on your health history, side effects, and insurance coverage.
Is Ozempic or Mounjaro better?
Ozempic and Wegovy contain the same active ingredient, semaglutide, while Mounjaro and Zepbound contain tirzepatide. Tirzepatide has shown greater average weight loss in trials, but Ozempic is approved for type 2 diabetes rather than weight loss, so the right pick depends on what is being treated. Ask your prescriber which one matches your diagnosis and your coverage.
Can I get a GLP-1 without a prescription?
No. Every FDA-approved GLP-1 in the United States requires a prescription from a licensed healthcare provider. Compounded versions also require a prescription and may only be prepared under limited legal conditions, and research-grade peptides sold online are not approved for human use.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.